TM Capital advised Epic Therapeutics in its acquisition by Baxter Healthcare Corporation (NYSE:BAX) subsequent to a collaboration agreement and investment by Baxter

TM Capital advised Freedom Innovations and ACT Medical in a leveraged recapitalization led by Telegraph Hill Partners and Tailwind Capital Group whereby they acquired a 73% stake in the combined company